Qiagen (QGEN) Financials

$44.90 +0.53 (+1.18%)

Closing price 05/29/2025 03:59 PM Eastern

Extended Trading

$45.00 +0.10 (+0.22%)

As of 05/29/2025 04:09 PM Eastern

Annual Income Statements for Qiagen

This table shows Qiagen's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Net Income / (Loss) Attributable to Common Shareholders	84	341	423	513	359	-41	190	40	80	130	116
Consolidated Net Income / (Loss)	84	341	423	513	359	-41	190	40	80	130	117
Net Income / (Loss) Continuing Operations	84	341	423	513	359	-41	190	40	80	130	117
Total Pre-Tax Income	121	430	513	626	439	-78	226	114	57	136	119
Total Operating Income	98	410	531	630	386	-26	267	153	99	179	162
Total Gross Profit	967	1,234	1,385	1,451	1,233	1,005	1,001	923	845	827	865
Total Revenue	1,978	1,965	2,142	2,252	1,870	1,526	1,502	1,418	1,338	1,281	1,345
Operating Revenue	1,978	1,965	2,142	2,252	1,870	1,526	1,502	1,418	1,338	1,281	1,345
Total Cost of Revenue	1,011	732	757	801	638	521	501	495	493	454	480
Operating Cost of Revenue	1,011	732	757	801	638	521	501	495	493	454	480
Total Operating Expenses	870	824	853	821	846	1,031	734	769	746	647	704
Selling, General & Admin Expense	113	119	130	128	112	112	105	102	-	-	127
Marketing Expense	451	460	474	456	414	392	392	376	376	360	376
Research & Development Expense	193	199	190	190	149	157	162	154	150	147	164
Amortization Expense	9.60	11	15	19	21	30	39	39	39	39	37
Restructuring Charge	102	35	45	28	151	200	29	98	181	102	-
Total Other Income / (Expense), net	23	20	-19	-4.25	53	-52	-41	-39	-42	-43	-42
Interest Expense	44	53	58	54	71	74	67	50	39	37	39
Interest & Investment Income	68	79	33	9.56	10	22	21	11	6.78	4.75	3.96
Other Income / (Expense), net	-0.74	-5.71	6.74	41	114	0.43	5.60	-0.00	-9.67	-11	-6.94
Income Tax Expense	38	89	89	113	80	-36	35	74	-23	6.40	2.46
Basic Earnings per Share	$0.38	$1.50	$1.86	$2.25	$1.57	($0.18)	$0.84	$0.18	$0.34	$0.56	$0.50
Weighted Average Basic Shares Outstanding	222.62M	228.15M	227.58M	227.98M	228.43M	226.78M	226.64M	228.07M	234.80M	233.48M	232.64M
Diluted Earnings per Share	$0.37	$1.48	$1.84	$2.21	$1.53	($0.18)	$0.82	$0.17	$0.34	$0.55	$0.48
Weighted Average Diluted Shares Outstanding	224.72M	230.62M	230.14M	232.03M	234.21M	226.78M	233.46M	233.01M	238.99M	238.65M	242.81M
Weighted Average Basic & Diluted Shares Outstanding	222.29M	228.20M	227.72M	227.07M	227.99M	227.75M	225.51M	226.56M	234.56M	233.01M	232.02M

No quarterly income statements for Qiagen are available.

This table details how cash moves in and out of Qiagen's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Net Change in Cash & Equivalents	-4.53	-63	-150	283	-31	-530	501	219	149	-103	62
Net Cash From Operating Activities	674	459	715	639	458	331	359	287	342	317	288
Net Cash From Continuing Operating Activities	674	459	715	639	458	331	359	287	342	317	288
Net Income / (Loss) Continuing Operations	84	341	423	513	359	-41	190	40	80	130	117
Consolidated Net Income / (Loss)	84	341	423	513	359	-41	190	40	80	130	117
Depreciation Expense	203	205	208	215	205	231	206	216	213	191	201
Amortization Expense	18	30	34	32	42	41	36	25	20	20	15
Non-Cash Adjustments To Reconcile Net Income	256	59	91	14	-70	210	46	36	90	42	75
Changes in Operating Assets and Liabilities, net	112	-176	-41	-135	-79	-110	-118	-31	-62	-66	-120
Net Cash From Investing Activities	-249	-88	-727	-202	-443	-222	-211	-464	-179	-146	-408
Net Cash From Continuing Investing Activities	-249	-88	-727	-202	-443	-222	-211	-464	-179	-146	-408
Purchase of Property, Plant & Equipment	-167	-150	-129	-190	-133	-118	-110	-90	-75	-98	-87
Acquisitions	-4.07	-163	-84	-17	-411	-225	-214	-85	-110	-87	-171
Purchase of Investments	-688	-979	-1,387	-400	-50	-294	-577	-455	-520	-324	-430
Sale and/or Maturity of Investments	585	1,271	883	360	207	391	692	189	534	368	276
Other Investing Activities, net	25	-67	-9.77	45	-58	23	-19	-23	-8.80	-5.98	3.61
Net Cash From Financing Activities	-423	-434	-126	-150	-50	-639	360	387	-11	-259	193
Net Cash From Continuing Financing Activities	-423	-434	-126	-150	-50	-639	360	387	-11	-259	193
Repayment of Debt	-602	-400	-480	-43	-365	-518	486	140	-18	-253	-392
Repurchase of Common Equity	-292	0.00	0.00	-100	-239	-74	-105	-61	0.00	-21	-127
Issuance of Debt	494	0.00	371	0.00	557	0.00	0.00	330	0.00	1.59	733
Other Financing Activities, net	-23	-34	-17	-15	-11	-49	-97	-74	0.78	3.33	-103
Effect of Exchange Rate Changes	-5.96	-0.56	-13	-3.68	4.20	0.83	-7.18	8.83	-2.77	-15	-11
Cash Interest Paid	24	20	23	22	25	30	26	20	18	21	24
Cash Income Taxes Paid	16	82	120	102	43	41	29	40	23	34	13

No quarterly cash flow statements for Qiagen are available.

This table presents Qiagen's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Total Assets	5,690	6,115	6,288	6,147	5,928	5,264	5,748	5,039	4,308	4,179	4,454
Total Current Assets	1,960	2,148	2,394	2,110	1,599	1,512	2,155	1,648	1,038	961	1,149
Cash & Equivalents	664	668	731	881	597	622	1,159	658	439	290	393
Short-Term Investments	489	390	688	185	14	108	235	359	93	131	184
Accounts Receivable	349	382	324	362	381	376	352	329	278	274	265
Inventories, net	279	398	358	328	291	171	163	156	137	137	132
Prepaid Expenses	178	310	294	355	-	-	109	99	67	70	114
Plant, Property, & Equipment, net	754	765	662	638	427	356	512	494	437	443	428
Total Noncurrent Assets	2,976	3,203	3,232	3,399	3,902	3,396	3,082	2,896	2,834	2,775	2,878
Goodwill	2,425	2,476	2,353	2,351	2,389	2,166	2,109	2,013	1,926	1,876	1,888
Intangible Assets	304	527	545	627	884	751	475	499	557	636	727
Other Noncurrent Operating Assets	247	200	334	421	529	392	455	345	283	261	258
Total Liabilities & Shareholders' Equity	5,690	6,115	6,288	6,147	5,928	5,264	5,748	5,039	4,308	4,179	4,454
Total Liabilities	2,122	2,307	2,821	3,050	3,445	2,940	3,113	2,498	1,701	1,611	1,796
Total Current Liabilities	544	1,079	975	1,517	571	951	972	325	308	268	432
Short-Term Debt	53	588	390	848	43	285	503	0.00	-	-	131
Accounts Payable	83	84	99	101	118	85	69	59	51	52	46
Accrued Expenses	407	407	486	569	-	-	263	242	230	192	224
Total Noncurrent Liabilities	1,579	1,228	1,847	1,533	2,874	1,989	2,141	2,173	1,393	1,343	1,365
Long-Term Debt	1,338	922	1,472	1,094	1,875	1,419	1,671	1,758	1,067	1,049	1,041
Other Noncurrent Operating Liabilities	241	306	375	439	953	542	407	338	285	224	207
Commitments & Contingencies	0.00	0.00	0.00	0.00	-	-	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	3,567	3,808	3,467	3,097	3,199	3,159	2,635	2,541	2,607	2,568	2,658
Total Preferred & Common Equity	3,567	3,808	3,467	3,097	2.70	2.70	2,635	2,541	2,607	2,566	2,650
Total Common Equity	3,567	3,808	3,467	3,097	1,359	1,368	2,635	2,541	2,607	2,566	2,650
Common Stock	1,669	1,918	1,871	1,821	2.70	2.70	1,745	1,633	1,797	1,768	1,826
Retained Earnings	2,448	2,457	2,160	1,792	998	948	1,380	1,248	1,263	1,209	1,126
Treasury Stock	-75	-133	-160	-190	118	112	-179	-119	-120	-152	-167
Accumulated Other Comprehensive Income / (Loss)	-475	-434	-404	-327	-	-	-311	-221	-334	-259	-135

No quarterly balance sheets for Qiagen are available.

This table displays calculated financial ratios and metrics derived from Qiagen's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.66%	-8.23%	-4.89%	20.39%	22.53%	1.64%	5.95%	5.95%	4.45%	-4.74%	3.29%
EBITDA Growth	-50.19%	-18.02%	-15.00%	22.71%	203.46%	-52.05%	30.29%	22.31%	-15.17%	2.55%	39.83%
EBIT Growth	-76.01%	-24.89%	-19.76%	33.95%	2,048.17%	-109.44%	77.41%	72.08%	-47.23%	9.17%	134.76%
NOPAT Growth	-79.29%	-25.81%	-14.98%	63.40%	1,826.34%	-108.14%	314.94%	-61.15%	-18.48%	8.02%	35.13%
Net Income Growth	-75.51%	-19.35%	-17.44%	42.71%	966.45%	-121.77%	371.31%	-49.70%	-38.18%	11.09%	69.23%
EPS Growth	-75.51%	-19.35%	-17.44%	42.71%	950.00%	-121.95%	382.35%	-50.00%	-38.18%	11.09%	69.23%
Operating Cash Flow Growth	46.60%	-35.76%	11.93%	39.58%	38.38%	-7.97%	25.36%	-16.05%	7.59%	10.26%	11.20%
Free Cash Flow Firm Growth	2,231.49%	-104.87%	145.57%	219.73%	-176.77%	142.61%	206.42%	-144.47%	-15.10%	142.43%	530.07%
Invested Capital Growth	-10.66%	8.95%	-1.59%	8.51%	15.33%	-7.05%	4.06%	4.47%	-1.70%	-1.76%	2.01%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EPS Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	48.90%	62.77%	64.65%	64.43%	65.91%	65.86%	66.65%	65.08%	63.13%	64.53%	64.34%
EBITDA Margin	16.11%	32.55%	36.44%	40.77%	40.00%	16.15%	34.23%	27.84%	24.12%	29.69%	27.58%
Operating Margin	4.94%	20.86%	24.82%	27.98%	20.66%	-1.71%	17.75%	10.82%	7.39%	14.01%	12.02%
EBIT Margin	4.90%	20.57%	25.13%	29.79%	26.77%	-1.68%	18.12%	10.82%	6.66%	13.19%	11.51%
Profit (Net Income) Margin	4.23%	17.37%	19.76%	22.77%	19.20%	-2.72%	12.68%	2.85%	6.00%	10.14%	8.70%
Tax Burden Percent	69.00%	79.41%	82.56%	81.91%	81.73%	53.30%	84.34%	35.32%	141.11%	95.30%	97.94%
Interest Burden Percent	124.93%	106.33%	95.24%	93.30%	87.76%	302.58%	82.94%	74.55%	63.83%	80.68%	77.15%
Effective Tax Rate	31.00%	20.59%	17.44%	18.09%	18.27%	0.00%	15.66%	64.68%	-41.11%	4.70%	2.06%
Return on Invested Capital (ROIC)	1.67%	7.97%	11.13%	13.52%	9.24%	-0.56%	6.71%	1.69%	4.40%	5.30%	4.92%
ROIC Less NNEP Spread (ROIC-NNEP)	6.36%	11.49%	8.77%	13.00%	27.37%	-6.37%	2.19%	-0.47%	-5.77%	-1.42%	-2.90%
Return on Net Nonoperating Assets (RNNOA)	0.60%	1.41%	1.76%	2.77%	2.06%	-0.88%	0.64%	-0.12%	-1.30%	-0.33%	-0.57%
Return on Equity (ROE)	2.27%	9.38%	12.90%	16.28%	11.30%	-1.43%	7.36%	1.57%	3.10%	4.97%	4.35%
Cash Return on Invested Capital (CROIC)	12.93%	-0.60%	12.74%	5.36%	-5.00%	6.75%	2.74%	-2.68%	6.11%	7.08%	2.92%
Operating Return on Assets (OROA)	1.64%	6.52%	8.66%	11.11%	8.95%	-0.47%	5.05%	3.28%	2.10%	3.91%	3.62%
Return on Assets (ROA)	1.42%	5.50%	6.81%	8.49%	6.42%	-0.75%	3.53%	0.86%	1.89%	3.01%	2.74%
Return on Common Equity (ROCE)	2.27%	9.38%	12.90%	11.52%	4.85%	-0.99%	7.36%	1.57%	3.10%	4.96%	4.33%
Return on Equity Simple (ROE_SIMPLE)	2.34%	8.96%	12.21%	16.55%	0.00%	-1,534.23%	7.23%	1.59%	3.08%	5.06%	4.41%
Net Operating Profit after Tax (NOPAT)	67	326	439	516	316	-18	225	54	139	171	158
NOPAT Margin	3.41%	16.56%	20.49%	22.92%	16.89%	-1.20%	14.97%	3.82%	10.42%	13.35%	11.78%
Net Nonoperating Expense Percent (NNEP)	-4.68%	-3.53%	2.36%	0.52%	-18.13%	5.82%	4.53%	2.16%	10.17%	6.73%	7.81%
Return On Investment Capital (ROIC_SIMPLE)	1.36%	6.12%	8.24%	10.24%	6.17%	-0.38%	4.68%	1.26%	3.80%	4.73%	4.13%
Cost of Revenue to Revenue	51.10%	37.23%	35.35%	35.57%	34.09%	34.14%	33.35%	34.92%	36.87%	35.47%	35.66%
SG&A Expenses to Revenue	5.73%	6.07%	6.06%	5.69%	5.97%	7.35%	6.96%	7.20%	0.00%	0.00%	9.42%
R&D to Revenue	9.78%	10.10%	8.87%	8.44%	7.97%	10.31%	10.78%	10.87%	11.20%	11.46%	12.17%
Operating Expenses to Revenue	43.96%	41.91%	39.84%	36.45%	45.25%	67.57%	48.90%	54.26%	55.74%	50.52%	52.31%
Earnings before Interest and Taxes (EBIT)	97	404	538	671	501	-26	272	153	89	169	155
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	319	640	780	918	748	247	514	395	323	380	371
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.77	2.38	2.99	3.75	8.12	5.10	2.71	2.62	2.29	2.29	1.90
Price to Tangible Book Value (P/TBV)	11.79	11.25	18.23	98.10	0.00	0.00	139.16	231.03	48.08	109.03	144.20
Price to Revenue (P/Rev)	4.99	4.61	4.85	5.16	5.90	4.58	4.76	4.69	4.47	4.59	3.74
Price to Earnings (P/E)	118.17	26.55	24.52	22.65	30.71	0.00	37.56	164.57	74.40	45.17	43.21
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.85%	3.77%	4.08%	4.41%	3.26%	0.00%	2.66%	0.61%	1.34%	2.21%	2.31%
Enterprise Value to Invested Capital (EV/IC)	2.66	2.23	2.77	3.14	3.87	3.07	2.32	2.25	2.07	2.04	1.73
Enterprise Value to Revenue (EV/Rev)	5.11	4.84	5.05	5.55	7.57	6.38	5.28	5.21	4.87	5.08	4.19
Enterprise Value to EBITDA (EV/EBITDA)	31.75	14.87	13.87	13.60	18.93	39.48	15.43	18.72	20.20	17.11	15.18
Enterprise Value to EBIT (EV/EBIT)	104.33	23.54	20.10	18.62	28.29	0.00	29.14	48.16	73.10	38.52	36.39
Enterprise Value to NOPAT (EV/NOPAT)	150.06	29.23	24.66	24.20	44.85	0.00	35.28	136.37	46.73	38.05	35.56
Enterprise Value to Operating Cash Flow (EV/OCF)	15.02	20.71	15.13	19.54	30.94	29.42	22.06	25.77	19.08	20.50	19.56
Enterprise Value to Free Cash Flow (EV/FCFF)	19.41	0.00	21.55	61.08	0.00	43.76	86.52	0.00	33.64	28.52	59.83
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.39	0.40	0.54	0.63	0.60	0.54	0.83	0.69	0.41	0.41	0.44
Long-Term Debt to Equity	0.38	0.24	0.42	0.35	0.59	0.45	0.63	0.69	0.41	0.41	0.39
Financial Leverage	0.09	0.12	0.20	0.21	0.08	0.14	0.29	0.25	0.22	0.23	0.20
Leverage Ratio	1.60	1.71	1.89	1.92	1.76	1.90	2.08	1.82	1.64	1.65	1.59
Compound Leverage Factor	2.00	1.81	1.80	1.79	1.55	5.75	1.73	1.35	1.05	1.33	1.22
Debt to Total Capital	28.06%	28.39%	34.94%	38.54%	37.48%	35.04%	45.21%	40.90%	29.04%	29.00%	30.60%
Short-Term Debt to Total Capital	1.08%	11.06%	7.31%	16.82%	0.83%	5.87%	10.46%	0.00%	0.00%	0.00%	3.42%
Long-Term Debt to Total Capital	26.98%	17.34%	27.63%	21.72%	36.65%	29.17%	34.75%	40.90%	29.04%	29.00%	27.18%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	35.96%	36.82%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.06%	0.22%
Common Equity to Total Capital	71.94%	71.61%	65.06%	61.46%	26.56%	28.14%	54.79%	59.10%	70.96%	70.94%	69.18%
Debt to EBITDA	4.37	2.36	2.39	2.12	2.56	6.91	4.23	4.46	3.31	2.76	3.16
Net Debt to EBITDA	0.75	0.71	0.57	0.95	1.73	3.89	1.52	1.88	1.66	1.65	1.61
Long-Term Debt to EBITDA	4.20	1.44	1.89	1.19	2.51	5.75	3.25	4.46	3.31	2.76	2.81
Debt to NOPAT	20.64	4.64	4.24	3.76	6.07	-93.13	9.67	32.45	7.65	6.13	7.40
Net Debt to NOPAT	3.54	1.39	1.01	1.70	4.10	-52.37	3.47	13.68	3.84	3.67	3.76
Long-Term Debt to NOPAT	19.85	2.83	3.35	2.12	5.94	-77.54	7.43	32.45	7.65	6.13	6.57
Altman Z-Score	4.10	3.67	3.58	3.53	2.96	2.08	2.38	2.64	3.10	3.23	2.64
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	29.23%	57.11%	30.90%	0.00%	0.00%	0.04%	0.20%	0.33%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.61	1.99	2.46	1.39	2.80	1.59	2.22	5.07	3.36	3.58	2.66
Quick Ratio	2.76	1.33	1.79	0.94	1.74	1.16	1.80	4.14	2.63	2.59	1.95
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	521	-24	502	204	-171	222	92	-86	194	228	94
Operating Cash Flow to CapEx	402.90%	306.90%	553.51%	336.49%	344.77%	280.49%	327.49%	318.51%	458.69%	325.05%	332.69%
Free Cash Flow to Firm to Interest Expense	11.89	-0.46	8.60	3.75	-2.39	3.00	1.36	-1.73	4.96	6.10	2.39
Operating Cash Flow to Interest Expense	15.36	8.60	12.26	11.73	6.42	4.46	5.34	5.77	8.75	8.49	7.32
Operating Cash Flow Less CapEx to Interest Expense	11.55	5.80	10.04	8.24	4.56	2.87	3.71	3.96	6.85	5.88	5.12
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.34	0.32	0.34	0.37	0.33	0.28	0.28	0.30	0.32	0.30	0.31
Accounts Receivable Turnover	5.41	5.57	6.24	6.06	4.94	4.19	4.41	4.67	4.85	4.75	5.12
Inventory Turnover	2.98	1.93	2.21	2.59	2.76	3.12	3.14	3.38	3.61	3.38	3.68
Fixed Asset Turnover	2.61	2.75	3.29	4.23	4.77	3.52	2.99	3.05	3.04	2.94	3.08
Accounts Payable Turnover	12.08	8.00	7.57	7.30	6.28	6.76	7.79	8.97	9.53	9.23	9.89
Days Sales Outstanding (DSO)	67.45	65.53	58.45	60.19	73.85	87.03	82.72	78.20	75.31	76.80	71.24
Days Inventory Outstanding (DIO)	122.34	188.67	165.27	140.99	132.20	116.83	116.17	107.84	101.04	108.00	99.08
Days Payable Outstanding (DPO)	30.23	45.62	48.21	49.99	58.08	53.99	46.86	40.71	38.30	39.54	36.91
Cash Conversion Cycle (CCC)	159.57	208.57	175.51	151.19	147.97	149.86	152.03	145.32	138.05	145.26	133.41
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	3,806	4,260	3,910	3,973	3,661	3,175	3,415	3,282	3,142	3,196	3,253
Invested Capital Turnover	0.49	0.48	0.54	0.59	0.55	0.46	0.45	0.44	0.42	0.40	0.42
Increase / (Decrease) in Invested Capital	-454	350	-63	312	487	-241	133	140	-54	-57	64
Enterprise Value (EV)	10,117	9,514	10,819	12,487	14,165	9,733	7,932	7,389	6,517	6,509	5,631
Market Capitalization	9,878	9,062	10,376	11,611	11,029	6,984	7,151	6,648	5,982	5,878	5,028
Book Value per Share	$15.63	$16.72	$15.23	$13.58	$5.97	$6.07	$11.63	$10.83	$11.19	$11.06	$11.33
Tangible Book Value per Share	$3.67	$3.54	$2.50	$0.52	($8.40)	($6.87)	$0.23	$0.12	$0.53	$0.23	$0.15
Total Capital	4,959	5,318	5,328	5,038	5,117	4,863	4,809	4,299	3,674	3,617	3,830
Total Debt	1,392	1,510	1,861	1,942	1,918	1,704	2,174	1,758	1,067	1,049	1,172
Total Long-Term Debt	1,338	922	1,472	1,094	1,875	1,419	1,671	1,758	1,067	1,049	1,041
Net Debt	239	452	443	876	1,296	958	781	741	535	628	595
Capital Expenditures (CapEx)	167	150	129	190	133	118	110	90	74	98	87
Debt-free, Cash-free Net Working Capital (DFCFNWC)	317	598	391	374	459	109	292	306	197	272	272
Debt-free Net Working Capital (DFNWC)	1,470	1,656	1,809	1,440	1,070	846	1,686	1,323	729	693	848
Net Working Capital (NWC)	1,416	1,068	1,419	592	1,028	560	1,183	1,323	729	693	717
Net Nonoperating Expense (NNE)	-16	-16	16	3.48	-43	23	34	14	59	41	41
Net Nonoperating Obligations (NNO)	239	452	443	876	463	16	781	741	535	628	595
Total Depreciation and Amortization (D&A)	222	235	242	247	247	272	242	241	234	211	216
Debt-free, Cash-free Net Working Capital to Revenue	16.01%	30.45%	18.24%	16.63%	24.56%	7.17%	19.46%	21.61%	14.72%	21.25%	20.19%
Debt-free Net Working Capital to Revenue	74.29%	84.27%	84.47%	63.94%	57.23%	55.39%	112.26%	93.34%	54.50%	54.10%	63.08%
Net Working Capital to Revenue	71.59%	54.36%	66.28%	26.30%	54.96%	36.71%	78.76%	93.34%	54.50%	54.10%	53.33%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.38	$1.54	$1.97	$0.00	$0.00	($0.19)	$0.89	$0.19	$0.36	$0.57	$0.53
Adjusted Weighted Average Basic Shares Outstanding	222.62M	221.81M	214.62M	0.00	0.00	213.86M	213.73M	215.09M	221.43M	219.95M	219.16M
Adjusted Diluted Earnings per Share	$0.37	$1.52	$1.95	$0.00	$0.00	($0.19)	$0.87	$0.18	$0.36	$0.57	$0.51
Adjusted Weighted Average Diluted Shares Outstanding	224.72M	224.21M	217.03M	0.00	0.00	213.86M	220.16M	219.74M	225.38M	223.42M	227.54M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	222.29M	221.86M	214.75M	0.00	0.00	214.78M	212.67M	213.66M	221.20M	219.50M	218.58M
Normalized Net Operating Profit after Tax (NOPAT)	138	354	476	539	439	220	256	176	196	268	158
Normalized NOPAT Margin	6.97%	17.99%	22.22%	23.93%	23.49%	14.38%	17.03%	12.42%	14.62%	20.95%	11.78%
Pre Tax Income Margin	6.12%	21.87%	23.94%	27.79%	23.50%	-5.10%	15.03%	8.07%	4.25%	10.64%	8.88%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	2.21	7.57	9.22	12.31	7.02	-0.35	4.04	3.09	2.28	4.52	3.93
NOPAT to Interest Expense	1.54	6.09	7.52	9.47	4.43	-0.25	3.34	1.09	3.57	4.57	4.03
EBIT Less CapEx to Interest Expense	-1.60	4.77	7.01	8.83	5.16	-1.94	2.41	1.28	0.38	1.91	1.73
NOPAT Less CapEx to Interest Expense	-2.28	3.29	5.30	5.99	2.57	-1.84	1.71	-0.72	1.67	1.96	1.83
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	349.44%	0.00%	0.00%	19.51%	66.43%	-179.59%	54.99%	150.94%	0.00%	16.03%	108.51%

No quarterly metrics and ratios for Qiagen are available.

Frequently Asked Questions About Qiagen's Financials

When does Qiagen's financial year end?

According to the most recent income statement we have on file, Qiagen's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Qiagen's net income changed over the last 10 years?

Qiagen's net income appears to be on an upward trend, with a most recent value of $83.59 million in 2024, falling from $116.93 million in 2014. The previous period was $341.30 million in 2023. Check out Qiagen's forecast to explore projected trends and price targets.

What is Qiagen's operating income?

Qiagen's total operating income in 2024 was $97.71 million, based on the following breakdown:

Total Gross Profit: $967.35 million
Total Operating Expenses: $869.64 million

How has Qiagen revenue changed over the last 10 years?

Over the last 10 years, Qiagen's total revenue changed from $1.34 billion in 2014 to $1.98 billion in 2024, a change of 47.1%.

How much debt does Qiagen have?

Qiagen's total liabilities were at $2.12 billion at the end of 2024, a 8.0% decrease from 2023, and a 18.1% increase since 2014.

How much cash does Qiagen have?

In the past 10 years, Qiagen's cash and equivalents has ranged from $290.01 million in 2015 to $1.16 billion in 2018, and is currently $663.56 million as of their latest financial filing in 2024.

How has Qiagen's book value per share changed over the last 10 years?

Over the last 10 years, Qiagen's book value per share changed from 11.33 in 2014 to 15.63 in 2024, a change of 38.0%.

Related Companies

This page (NYSE:QGEN) was last updated on 5/30/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Qiagen (QGEN) Financials

Frequently Asked Questions About Qiagen's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Qiagen (QGEN) Financials

Annual Income Statements for Qiagen

Quarterly Income Statements for Qiagen

Annual Cash Flow Statements for Qiagen

Quarterly Cash Flow Statements for Qiagen

Annual Balance Sheets for Qiagen

Quarterly Balance Sheets for Qiagen

Annual Metrics And Ratios for Qiagen

Quarterly Metrics And Ratios for Qiagen

Frequently Asked Questions About Qiagen's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools